Wuxi Lead Intelligent (300450) Report Interpretation

Overview

Morgan Stanley reviews Wuxi Lead Intelligent's 2Q26 results and concludes that earnings were largely in line, while strong order momentum and expansion beyond battery equipment reinforce its Overweight thesis. The report sees margin recovery, sustained battery-equipment demand, and new-business progress as the key supports for its outlook.

Core views

Wuxi Lead's 2Q26 operating results were broadly consistent with Morgan Stanley's expectations, apart from gross margin. Revenue reached Rmb4.498bn, up 28% year on year and 22% quarter on quarter, versus Morgan Stanley's Rmb4.566bn estimate. Net profit attributable to shareholders was Rmb551mn, up 47% year on year and 36% quarter on quarter, matching the estimate, with a 12.2% net margin. Lower operating expenses helped offset pressure on gross profit: selling, administrative, and R&D expenses as a percentage of revenue declined year on year. The main shortfall was gross margin, which was 30.6%, down 2.5 percentage points year on year and 3.4 percentage points below Morgan Stanley's estimate. The report attributes the miss to raw-material cost inflation and higher shipping costs. Management nevertheless indicated that gross margin improved during July and August. With cost pressure stabilizing and operating-expense control continuing, management believes net margin could move back toward its historical high. Order momentum is the central positive. New orders exceeded Rmb9bn in 2Q, growing more than 40% year on year and remaining close to Rmb9.6bn in 1Q; about 80% came from lithium-ion battery equipment. First-half orders grew by more than 50% year on year. Management expects 3Q orders to be similar to the first two quarters, implying FY26 orders could exceed its prior guidance of 30% year-on-year growth. For 2027, management is constructive because major customers have favorable demand outlooks and nearly full utilization, while overseas business is growing. Morgan Stanley relays management's view that the current battery-equipment upcycle could last three to five years. The stated reasons are that demand is being driven by leading customers with healthier fundamentals and less sensitivity to regulatory tightening, capacity expansion has become more rational, and overseas demand is contributing. The report also expects market-share gains to help Wuxi Lead outperform. It argues that the market remains negative on battery-equipment prospects and underestimates the company's expansion into adjacent businesses. Those adjacent businesses provide the report's medium-term upside case. MLCC and SOFC equipment can use technological know-how developed in new-energy equipment and existing customer relationships, with targeted gross margins above 40-50%. Initial humanoid-related orders are expected to materialize in 3Q, focused on production automation. Solid-state battery and sodium-ion battery initiatives are progressing as planned; the FY26 solid-state battery order target remains about twice the prior level. Morgan Stanley considers valuation attractive if order growth is sustained into 2027. It notes that the stock trades at about 1.5x 2026 new orders, or roughly 10x implied P/E assuming a 15% margin. Its base case applies a 2.5x market-cap-to-new-orders multiple to its Rmb36bn 2026 new-orders forecast. The report views this multiple as consistent with the stock's 2023 trading level and argues that the comparison is supported by high order levels being sustained into 2027, unlike the order decline in 2024, with replacement demand, sodium-battery commercialization, and a gradual solid-state-battery ramp as supports.

Analysis framework

The report first compares 2Q26 revenue, profitability, and expenses with Morgan Stanley estimates, then focuses on the order book and management's outlook for 3Q, FY26, and 2027. It links battery-equipment demand, customer utilization, overseas expansion, and adjacent businesses to future order growth, and applies a market-cap-to-new-orders multiple to its 2026 order forecast for valuation.

Methodology notes

• Corporate Fundamentals and FinanceEarnings Quality Analysis

  Earnings and margin analysis

  Morgan Stanley compares revenue, gross margin, net profit, and operating expenses with its estimates to distinguish an in-line profit result from the gross-margin miss and assess potential margin recovery.

• Other

  Market capitalization-to-new-orders valuation

  The report values Wuxi Lead by applying a 2.5x market-cap-to-new-orders multiple to its Rmb36bn 2026 order forecast, using sustained order growth as the basis for the multiple.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Wuxi Lead Intelligent (300450.SZ)

  Primary covered company; battery-equipment order momentum and adjacent-business expansion underpin the report's Overweight view.

  Strengths

  More than Rmb9bn of 2Q new orders, constructive 2027 outlook, potential market-share gains, and expansion into MLCC, SOFC, and humanoid automation.

  Weaknesses

  2Q gross margin fell to 30.6% because of raw-material cost inflation and higher shipping costs.

  Comparison

  Morgan Stanley considers its 2.5x market-cap-to-new-orders multiple consistent with the level at which the stock traded in 2023.

  Risks

  Weaker-than-expected ESS demand, limited overseas-expansion progress amid global EV deceleration, and slower sodium- or solid-state-battery adoption.

Key data

• 2Q26 revenueRmb4.498bn+28% year on year and +22% quarter on quarter; 1% below Morgan Stanley's Rmb4.566bn estimate
• 2Q26 gross margin30.6%-2.5 percentage points year on year and 3.4% below Morgan Stanley's estimate, due to raw-material inflation and shipping costs
• 2Q26 net profit attributable to shareholdersRmb551mn+47% year on year and +36% quarter on quarter; in line with estimate
• 2Q26 net margin12.2%Helped by lower operating expenses
• 2Q26 new orders>Rmb9bnMore than 40% year-on-year growth; about 80% from lithium-ion batteries
• 1H26 new-order growth>50% year on yearManagement expects 3Q new orders to remain similar to 1Q and 2Q
• 2026 new-orders forecastRmb36bnUsed in Morgan Stanley's base-case valuation at a 2.5x market-cap-to-new-orders multiple

Impact & implications

Morgan Stanley's conclusion is that the order outlook matters more than the 2Q gross-margin miss. It sees sustained battery-equipment orders, possible margin normalization, market-share gains, and higher-margin adjacent businesses as supporting earnings and valuation if growth continues into 2027.

Risks

• ESS demand could be weaker than expected.
• Overseas expansion could progress slowly if global EV growth decelerates.
• Adoption of sodium-ion and solid-state batteries could be slower than expected.

What to watch

• Whether 3Q new orders remain similar to the more than Rmb9bn recorded in 2Q and the Rmb9.6bn recorded in 1Q.
• Gross-margin improvement during July and August and whether net margin moves toward historical highs.
• Progress in overseas expansion, sodium-ion and solid-state battery commercialization, and initial humanoid automation orders.
• Whether ESS demand is stronger than expected.